• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita

• Solvents and Organic Chemicals Organic Compounds cyanides/Cyanides

Recent Advances in the Application of 2-Bromo-6-methoxybenzonitrile (CAS: 1245647-50-0) in Chemical Biology and Pharmaceutical Research

2-Bromo-6-methoxybenzonitrile (CAS: 1245647-50-0) is a versatile chemical intermediate that has garnered significant attention in recent years due to its potential applications in drug discovery and chemical biology. This compound, characterized by its bromine and methoxy functional groups, serves as a key building block in the synthesis of various pharmacologically active molecules. Recent studies have highlighted its role in the development of kinase inhibitors, antimicrobial agents, and other therapeutic compounds, making it a subject of intense research in the pharmaceutical industry.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 2-Bromo-6-methoxybenzonitrile in the synthesis of novel Bruton's tyrosine kinase (BTK) inhibitors. The researchers utilized this compound as a precursor to develop a series of potent and selective BTK inhibitors, which showed promising results in preclinical models of autoimmune diseases and B-cell malignancies. The study underscored the importance of the bromine moiety in facilitating cross-coupling reactions, a critical step in the synthetic pathway.

In addition to its role in kinase inhibitor development, 2-Bromo-6-methoxybenzonitrile has been explored as a scaffold for antimicrobial agents. A recent publication in Bioorganic & Medicinal Chemistry Letters reported the synthesis of a new class of antibacterial compounds derived from this intermediate. The compounds exhibited broad-spectrum activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), with minimal cytotoxicity against mammalian cells. The methoxy group was found to enhance the compounds' bioavailability, a key factor in their therapeutic potential.

Another emerging application of 2-Bromo-6-methoxybenzonitrile is in the field of chemical proteomics. Researchers have employed this compound as a reactive handle for the development of activity-based probes (ABPs) targeting cysteine proteases. A 2024 study in Nature Chemical Biology described the design of such probes, which enabled the selective labeling and profiling of caspase-family proteases in live cells. This approach provides a powerful tool for studying protease activity in disease contexts and for identifying new drug targets.

Despite these advancements, challenges remain in the large-scale production and optimization of 2-Bromo-6-methoxybenzonitrile-derived compounds. Recent efforts have focused on developing more efficient synthetic routes and improving the compound's stability under various conditions. A 2023 patent application disclosed a novel catalytic system for the bromination of 6-methoxybenzonitrile, offering a more sustainable and cost-effective method for producing this valuable intermediate.

Looking ahead, the unique chemical properties of 2-Bromo-6-methoxybenzonitrile position it as a promising candidate for further exploration in drug discovery and chemical biology. Ongoing research aims to expand its applications to other therapeutic areas, such as neurodegenerative diseases and cancer immunotherapy. As synthetic methodologies continue to advance, this compound is expected to play an increasingly important role in the development of next-generation pharmaceuticals.

• 73289-86-8(2,4-Dibromo-6-Hydroxybenzonitrile)
• 330793-38-9(4-Bromo-2-methoxybenzonitrile)
• 73289-85-7(2-Bromo-6-hydroxybenzonitrile)
• 1020922-43-3(Benzonitrile,2-(3-bromophenoxy)-)
• 875664-25-8(4-Bromo-2-phenoxybenzonitrile)
• 1255870-63-3(4-Bromo-2-ethoxybenzonitrile)
• 144649-99-0(5-Bromo-2-methoxybenzonitrile)
• 140860-51-1(2-Bromo-4-methoxybenzonitrile)
• 62827-45-6(Benzonitrile, 2-bromo-4,6-dimethoxy-)
• 609788-39-8(Benzonitrile, 4-bromo-2-methoxy-5-methyl-)